Please login to the form below

Not currently logged in
Email:
Password:

EU proposes vaccine-sharing mechanism with low-income countries

EU flag

Mechanism could provide low-income countries with early access to COVID-19 vaccines

Valneva set to begin commercial manufacturing of COVID-19 vaccine within days

covidVaccine could be in use in Britain by September

WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”

WHOTedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility

Lilly partners with Merus on development of bispecific antibodies for cancer

Eli Lilly new HQAs part of the deal, Merus could receive a total of up to around $1.6bn for three products

GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours

GSK - logo on buildingInvestigational PD-1 inhibitor is being studied in mismatch repair-deficient solid tumours

NHS is set to begin offering COVID-19 vaccinations to over-70s this week

Vaccine vialAnnouncement comes as ten new vaccination centres open in England

Cambridge University develops DNA test for secondary infections in COVID-19 patients

Interim analysis clinical trialsTest can identify cases of ‘ventilator-associated pneumonia’

Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU

Pfizer Biontech'Temporary' reduction comes as companies bolster production capacity for the year

Amgen strikes $240m autoimmune deal with Evoq Therapeutics

Amgen flagCompanies will collaborate on novel drugs for autoimmune disorders

Shairose EbrahimQ&A: Shairose Ebrahim

PME interviews integrated medhealth communication (imc) group's President and CEO

Latest appointments

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics